Ozanimod beats placebo for ulcerative colitis
(HealthDay)—For patients with moderately to severely active ulcerative colitis, ozanimod is more effective than placebo as induction and maintenance therapy, according to a study published in the Sept
Updated on: February 19,2024
Ozanimod beats placebo for ulcerative colitis
(HealthDay)—For patients with moderately to severely active ulcerative colitis, ozanimod is more effective than placebo as induction and maintenance therapy, according to a study published in the Sept
Updated on:February 19,2024
